Clinical Trial: A Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Lassa Virus Infection
Study Type: INTERVENTIONAL
Official Title: A Comparative, Randomized, Two-Period, Crossover Study to Compare Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in
Brief Summary:
ARN-75039-103 is a comparative, randomized, single-dose, crossover study to assess the PK, safety, and tolerability of neat ARN-75039 in hydroxypropyl methylcellulose (HPMC) capsules against ARN 75039 with excipients in tablet form administered by the oral route in healthy adult participants.The safety assessments will include standard evaluations of vital signs, clinical laboratory values, and ECGs.Participants will be admitted to the study site on the morning of Day -1, prior to Period 1 study drug…
Read more